{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:25:05Z","timestamp":1790861105491,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Liaoning Provincial Science and Technology Department","doi-asserted-by":"crossref","award":["2009ZX09301-012"],"award-info":[{"award-number":["2009ZX09301-012"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ijpharm.2012.06.054","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T02:02:05Z","timestamp":1341280925000},"page":"341-350","source":"Crossref","is-referenced-by-count":76,"title":["Thiolated Eudragit nanoparticles for oral insulin delivery: Preparation, characterization and in vivo evaluation"],"prefix":"10.1016","volume":"436","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkuo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.06.054_bib0005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.addr.2005.07.002","article-title":"Thiomers: a new generation of mucoadhesive polymers","volume":"57","author":"Bernkop-Schnurch","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2003.05.001","article-title":"Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer\/GSH systems","volume":"93","author":"Bernkop-Schnurch","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0015","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1023\/A:1018830204170","article-title":"Polymers with thiol groups: a new generation of mucoadhesive polymers?","volume":"16","author":"Bernkop-Schn\u00fcrch","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0020","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-5173(01)00807-9","article-title":"Thiolated polymers: synthesis and in vitro evaluation of polymer\u2013cysteamine conjugates","volume":"226","author":"Bernkop-Schn\u00fcrch","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2006.02.044","article-title":"Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system","volume":"317","author":"Bernkop-Schn\u00fcrch","year":"2006","journal-title":"Int. J. pharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0735-6757(93)90018-7","article-title":"Gas gangrene from subcutaneous insulin administration","volume":"11","author":"Chin","year":"1993","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2006.10.023","article-title":"Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats","volume":"117","author":"Damge","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.21874","article-title":"Poly (\u025b-caprolactone)\/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes","volume":"99","author":"Damg\u00e9","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2011.01.060","article-title":"Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa","author":"Dunnhaupt","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0003-2697(73)90169-3","article-title":"A sensitive method for localization of disulfide containing peptides in column effluents","volume":"56","author":"Habeeb","year":"1973","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1208\/s12249-010-9488-7","article-title":"Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights","volume":"11","author":"Jelvehgari","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0939-6411(00)00084-9","article-title":"Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?","volume":"50","author":"Jung","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(01)00579-8","article-title":"Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat","volume":"216","author":"Kisel","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpb.2003.09.011","article-title":"Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system","volume":"57","author":"Krauland","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jconrel.2003.12.017","article-title":"Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats","volume":"95","author":"Krauland","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1262-3636(06)72804-X","article-title":"Alternatives routes of insulin delivery","volume":"32","author":"Lassmann-Vague","year":"2006","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.2042-7158.1992.tb03633.x","article-title":"Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat","volume":"44","author":"Lehr","year":"1992","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0095","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1021\/ma970399k","article-title":"Analysis of the complexation\/decomplexation phenomena in graft copolymer networks","volume":"30","author":"Lowman","year":"1997","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/js980337n","article-title":"Oral delivery of insulin using pH-responsive complexation gels","volume":"88","author":"Lowman","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0168-3659(94)90078-7","article-title":"Bioadhesive polymers for the peroral delivery of peptide drugs","volume":"29","author":"Lue\u00dfen","year":"1994","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2010.02.001","article-title":"A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa","volume":"149","author":"Makhlof","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.addr.2011.10.006","article-title":"Oral colon delivery of insulin with the aid of functional adjuvants","volume":"64","author":"Maroni","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0120","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0142-9612(00)00039-9","article-title":"Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro","volume":"21","author":"Marsch\u00fctz","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0125","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1023\/A:1007696723125","article-title":"Design and in vivo evaluation of an oral delivery system for insulin","volume":"17","author":"Marsch\u00fctz","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0928-0987(97)10007-0","article-title":"Binding and uptake of biodegradable poly-lactide micro-and nanoparticles in intestinal epithelia","volume":"6","author":"McClean","year":"1998","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0135","unstructured":"Methacrylic Acid Methylmethacrylate Copolymer. (1:1). European Pharmacopoeia, 7th ed., Strasburg, France, 2000, p. 2461."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0378-5173(93)90418-F","article-title":"Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100","volume":"91","author":"Morishita","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0168-3659(02)00019-6","article-title":"Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers","volume":"81","author":"Morishita","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2005.10.029","article-title":"Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats","volume":"110","author":"Morishita","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0155","first-page":"1","article-title":"pH-sensitive oral insulin delivery systems using Eudragit microspheres","author":"Mundargi","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2006.12.007","article-title":"Nanoparticulate delivery system for insulin: design, characterization and in vitro\/in vivo bioactivity","volume":"30","author":"Reis","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0165","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.actbio.2010.02.007","article-title":"Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery","volume":"6","author":"Sajeesh","year":"2010","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0170","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0175","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-Responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0180","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-0987(01)00172-5","article-title":"Chitosan and its derivatives in mucosal drug and vaccine delivery","volume":"14","author":"van der Lubben","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2004.04.013","article-title":"Oral delivery of macromolecules using intestinal patches: applications for insulin delivery","volume":"98","author":"Whitehead","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2009.06.002","article-title":"Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin","volume":"73","author":"Woitiski","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0200","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2010.09.016","article-title":"Preparation and evaluation of alginate\u2013chitosan microspheres for oral delivery of insulin","volume":"77","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.06.054_bib0210","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1016\/j.jconrel.2011.08.078","article-title":"An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid","volume":"152","author":"Zhao","year":"2011","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312006539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:12:05Z","timestamp":1588824725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312006539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0378517312006539"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.06.054","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}